Fiche traitement
Electrocardiogram
Centre Hospitalier Universitaire Dijon • Accident vasculaire cérébral
Suivi actif
À vérifier
Résumé
Electrocardiogram est développé par Centre Hospitalier Universitaire Dijon. Le traitement est actuellement en À vérifier. Il est associé à Accident vasculaire cérébral. Son objectif thérapeutique principal est Traitement symptomatique. Le statut actuel est : suivi actif.
À vérifier
Traitement symptomatique
À vérifier
Centre Hospitalier Universitaire Dijon
France
The aim of this study is to analyze the relationship between the blood biomarker GDF-15 and heart damage after stroke.
It is being conducted in France, in the Neurology Department of the Dijon University Hospital (Burgundy). The research is interventional because a biological blood test will be performed, as well as a heart rhythm recording and several cardiac echograms during the hospitalization of the participants and during the follow-up consultation scheduled 4 to 6 months after the stroke.
A total of 130 stroke patients will participate in this study.
Participation includes 4 visits:
* Inclusion visit (within 24 hours of the first stroke symptoms)
* visit 1 (within 24 to 72 hours of stroke)
* visit 2 (within 48 hours of visit 1)
* Visit 3 (approximately 4-6 months post-stroke)
2026-10-19
Début phase actuelle
Non disponible dans les sources synchronisées
Timeline clinique
À vérifier
Début phase actuelle
Non disponible dans les sources synchronisées
Préclinique
Phase 1
Phase 2
Phase 3
Approuvé
Objectif scientifique de l’étude
classification automatique vérifiable
Traitement symptomatique
Confiance automatique : 66%
Ce pourcentage n’est pas une probabilité de succès clinique.
Il mesure uniquement la force de la classification automatique de l’objectif scientifique. Le calcul part de 45 points, ajoute 7 points par unité de poids du mot-clé le plus fortement détecté, puis est plafonné à 95 %. Exemple : un score maximal de 2 donne 45 + (2 × 7) = 59 %.
Indices détectés : symptom → Traitement symptomatique
Ce score est heuristique et doit être vérifié dans le protocole ou une publication.
Description affichée depuis l’essai compatible NCT05683873, afin d’éviter le mélange entre plusieurs indications d’une même molécule.
Aucune incohérence majeure détectée entre la maladie, l’objectif et la description.
Transparence et qualité de la fiche
données vérifiablesClassificationCohérente automatiquement
Confiance de la fiche100 %
Source principaleSource officielle ou publication indexée
Dernière vérification2026-10-19
Anomalies détectées0
Validation humaineValidation humaine non effectuée
Donnée issue d’une source
Donnée normalisée automatiquement
Interprétation algorithmique
Classification scientifique multi-axes
ne pas confondre statut et résultatÉtat de l’étudeRecrutement en cours
Disponibilité des résultatsRésultats à vérifier
InterprétationImpossible à déterminer
Niveau de preuveNon évaluable
Un essai terminé n’est pas nécessairement positif. Un essai arrêté n’est classé comme échec scientifique que lorsqu’un résultat ou une raison explicite le confirme.
Indicateurs factuels
sans score subjectifPhase enregistréeÀ vérifier
Études associées1
Publications associées25
Statut consolidéSuivi actif
Aucune chance de succès, note d’innovation, potentiel thérapeutique ou probabilité de commercialisation n’est calculé tant qu’un modèle validé et des données suffisantes ne sont pas disponibles.
Historique factuel de la molécule
29 événement(s) daté(s)Cette liste reprend uniquement les dates trouvées dans les registres et publications liés. Elle ne constitue pas une prévision.
| Date | Événement | Source |
|---|---|---|
| 2023-02-13 | Début de l’étudeNCT05683873 | Registre d’essai clinique |
| 2026-07-12 | PublicationECG arrhythmia classification via wavelet-driven feature extraction and swarm-optimised gradient boosting. | Computers in biology and medicine |
| 2026-07-14 | PublicationNurse led first seizure clinics-a dangerous experiment or an effective alternative to the norm? | Epilepsy & behavior : E&B |
| 2026-07-22 | PublicationA varying presentation of refractory supra ventricular tachycardia in a newborn: A rare and unusual case report. | Journal of family medicine and primary care |
| 2026-08-08 | PublicationA randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy. | Clinical hypertension |
| 2026-08-08 | PublicationComplete autonomic blockade reveals nitric oxide contribution to blood pressure regulation in obese Black women. | Clinical autonomic research : official journal of the Clinical Autonomic Research Society |
| 2026-08-08 | PublicationA Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects. | CNS drugs |
| 2026-08-08 | PublicationWAVE: Wall-Aligned Vector Embedding for Self-Supervised Learning of Electrocardiograms. | Bioengineering (Basel, Switzerland) |
| 2026-08-13 | PublicationA Randomized, Double-Blinded, Placebo-Controlled QTc Study to Evaluate BIA 28-6156 Effect on Cardiac Repolarization in Healthy Volunteers. | Clinical pharmacology in drug development |
| 2026-08-13 | PublicationPharmacokinetics and Safety of a Novel Clofazimine Formulation and Dosing Strategy in Children With Rifampicin-resistant Tuberculosis. | The Journal of infectious diseases |
| 2026-08-16 | PublicationPerimenstrual eletriptan prevents menstrual migraine: an open-label study. | Headache |
| 2026-08-16 | PublicationA phase 1, multicenter, open-label study to evaluate the pharmacokinetics, safety, and tolerability of a single dose of rimegepant in children (aged ≥6 to <12 years) with a history of migraine. | Headache |
| 2026-08-16 | PublicationA Phase 1, Randomized, Placebo-Controlled, Multiple-Dose, Double-Blind Study to Evaluate and Compare the Pharmacokinetics and Safety of Rimegepant in Healthy Adult Japanese and Caucasian Individuals. | Clinical pharmacology in drug development |
| 2026-08-16 | PublicationA comparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization: Design and rationale of the randomized Elderly-ACS 2 study. | American heart journal |
| 2026-08-16 | PublicationA robust broadband fat-suppressing phaser T -preparation module for cardiac magnetic resonance imaging at 3T. | Magnetic resonance in medicine |
| 2026-08-16 | PublicationA pilot, open-label study of the effectiveness and tolerability of low-dose ZX008 (fenfluramine HCl) in Lennox-Gastaut syndrome. | Epilepsia |
| 2026-08-16 | PublicationA RAPID PROTOTYPING ENVIRONMENT FOR CLOSED-LOOP NEUROMODULATION USING THE BRAIN INTERCHANGE SYSTEM. | Proceedings of the ... Design of Medical Devices Conference. Design of Medical Devices Conference |
| 2026-08-16 | PublicationPersonalized topology-informed localization of standard 12-lead ECG electrode placement from incomplete cardiac MRIs for efficient cardiac digital twins. | Medical image analysis |
| 2026-08-16 | PublicationHemodynamic and thermal responses to head and neck cooling in men and women. | American journal of physical medicine & rehabilitation |
| 2026-08-16 | PublicationDetection of cardiac pathologies in electrocardiogram signals using empirical mode decomposition and neural networks. | Health information science and systems |
| 2026-08-16 | PublicationSafety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension. | Journal of child and adolescent psychopharmacology |
| 2026-08-16 | PublicationProtocol for simultaneous non-invasive electrocardiogram and respiratory plethysmography recordings in mice. | STAR protocols |
| 2026-08-16 | PublicationA pathogenic nonsense mutation (c.1522C>T) of the MYBPC3 gene is implicated with hypertrophic cardiomyopathy. | ESC heart failure |
| 2026-08-16 | PublicationAssessment of left ventricle strain of cardiovascular-asymptomatic patients of type 2 diabetes mellitus with preserved cardiovascular function through Dobutamine stress echocardiography. | Irish journal of medical science |
| 2026-08-16 | PublicationNew pulse sequence for improving cardiac black-blood and PSIR MRI quality in cases of arrhythmia. | Magnetic resonance letters |
| 2026-10-18 | PublicationSafety, tolerability, and pharmacokinetics/-dynamics of the dipeptidyl peptidase 3-inhibiting antibody Procizumab in a first-in-human trial. | mAbs |
| 2026-10-19 | Dernière mise à jour des donnéesElectrocardiogram | Biomedical Watch |
| 2026-10-25 | Création de l’enregistrementNCT05683873 | Registre d’essai clinique |
| 2027-08-01 | Fin de l’étude prévue / enregistréeNCT05683873 | Registre d’essai clinique |
Début phase actuelle
Non disponible dans les sources synchronisées
Essais cliniques liés
1 essai(s)
Début phase actuelle
Non disponible dans les sources synchronisées
| NCT | Titre | Phase | Statut administratif | Pays | Sponsor |
|---|---|---|---|---|---|
| NCT05683873 | Stroke-induced Myocardial Dysfunction: Role of GDF-15 (SMOG-15) Clinical Work Package | À vérifier | RECRUITING | France | Centre Hospitalier Universitaire Dijon |
Publications liées
25 publication(s)Publications liées
25 publication(s)| Titre | PMID | DOI | Journal | Date |
|---|---|---|---|---|
| Safety, tolerability, and pharmacokinetics/-dynamics of the dipeptidyl peptidase 3-inhibiting antibody Procizumab in a first-in-human trial. Voir source | 42165327 | 10.1080/19420862.2026.2671468 | mAbs | |
| Perimenstrual eletriptan prevents menstrual migraine: an open-label study. Voir source | 20236337 | 10.1111/j.1526-4610.2010.01628.x | Headache | |
| A phase 1, multicenter, open-label study to evaluate the pharmacokinetics, safety, and tolerability of a single dose of rimegepant in children (aged ≥6 to <12 years) with a history of migraine. Voir source | 41133671 | 10.1111/head.15074 | Headache | |
| A Phase 1, Randomized, Placebo-Controlled, Multiple-Dose, Double-Blind Study to Evaluate and Compare the Pharmacokinetics and Safety of Rimegepant in Healthy Adult Japanese and Caucasian Individuals. Voir source | 41273248 | 10.1002/cpdd.1630 | Clinical pharmacology in drug development | |
| A comparison of reduced-dose prasugrel and standard-dose clopidogrel in elderly patients with acute coronary syndromes undergoing early percutaneous revascularization: Design and rationale of the randomized Elderly-ACS 2 study. Voir source | 27823681 | 10.1016/j.ahj.2016.08.010 | American heart journal | |
| A robust broadband fat-suppressing phaser T -preparation module for cardiac magnetic resonance imaging at 3T. Voir source | 33759208 | 10.1002/mrm.28785 | Magnetic resonance in medicine | |
| A pilot, open-label study of the effectiveness and tolerability of low-dose ZX008 (fenfluramine HCl) in Lennox-Gastaut syndrome. Voir source | 30146701 | 10.1111/epi.14540 | Epilepsia | |
| A RAPID PROTOTYPING ENVIRONMENT FOR CLOSED-LOOP NEUROMODULATION USING THE BRAIN INTERCHANGE SYSTEM. Voir source | 42338924 | 10.1115/dmd2026-1009 | Proceedings of the ... Design of Medical Devices Conference. Design of Medical Devices Conference | |
| Personalized topology-informed localization of standard 12-lead ECG electrode placement from incomplete cardiac MRIs for efficient cardiac digital twins. Voir source | 39854816 | 10.1016/j.media.2025.103472 | Medical image analysis | |
| Hemodynamic and thermal responses to head and neck cooling in men and women. Voir source | 8985108 | 10.1097/00002060-199611000-00008 | American journal of physical medicine & rehabilitation | |
| Detection of cardiac pathologies in electrocardiogram signals using empirical mode decomposition and neural networks. Voir source | 42491352 | 10.1007/s13755-026-00471-w | Health information science and systems | |
| Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension. Voir source | 26978327 | 10.1089/cap.2015.0146 | Journal of child and adolescent psychopharmacology | |
| Protocol for simultaneous non-invasive electrocardiogram and respiratory plethysmography recordings in mice. Voir source | 42455681 | 10.1016/j.xpro.2026.104660 | STAR protocols | |
| A pathogenic nonsense mutation (c.1522C>T) of the MYBPC3 gene is implicated with hypertrophic cardiomyopathy. Voir source | 37271167 | 10.1002/ehf2.14424 | ESC heart failure | |
| Assessment of left ventricle strain of cardiovascular-asymptomatic patients of type 2 diabetes mellitus with preserved cardiovascular function through Dobutamine stress echocardiography. Voir source | 41212505 | 10.1007/s11845-025-04148-3 | Irish journal of medical science | |
| New pulse sequence for improving cardiac black-blood and PSIR MRI quality in cases of arrhythmia. Voir source | 42502572 | 10.1016/j.mrl.2026.200303 | Magnetic resonance letters | |
| A Randomized, Double-Blinded, Placebo-Controlled QTc Study to Evaluate BIA 28-6156 Effect on Cardiac Repolarization in Healthy Volunteers. Voir source | 41957689 | 10.1002/cpdd.70055 | Clinical pharmacology in drug development | |
| Pharmacokinetics and Safety of a Novel Clofazimine Formulation and Dosing Strategy in Children With Rifampicin-resistant Tuberculosis. Voir source | 42590848 | 10.1093/infdis/jiag381 | The Journal of infectious diseases | |
| A randomized, double-blind, multicenter, phase III study on the efficacy and safety of a combination treatment involving fimasartan, amlodipine, rosuvastatin in patients with essential hypertension and dyslipidemia who fail to respond adequately to fimasartan monotherapy. Voir source | 36451242 | 10.1186/s40885-022-00223-4 | Clinical hypertension | |
| Complete autonomic blockade reveals nitric oxide contribution to blood pressure regulation in obese Black women. Voir source | 39090323 | 10.1007/s10286-024-01050-3 | Clinical autonomic research : official journal of the Clinical Autonomic Research Society | |
| A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects. Voir source | 32676977 | 10.1007/s40263-020-00738-0 | CNS drugs | |
| WAVE: Wall-Aligned Vector Embedding for Self-Supervised Learning of Electrocardiograms. Voir source | 42510400 | 10.3390/bioengineering13070733 | Bioengineering (Basel, Switzerland) | |
| A varying presentation of refractory supra ventricular tachycardia in a newborn: A rare and unusual case report. Voir source | 42483369 | 10.4103/jfmpc.jfmpc_948_23 | Journal of family medicine and primary care | |
| Nurse led first seizure clinics-a dangerous experiment or an effective alternative to the norm? Voir source | 42208389 | 10.1016/j.yebeh.2026.111140 | Epilepsy & behavior : E&B | |
| ECG arrhythmia classification via wavelet-driven feature extraction and swarm-optimised gradient boosting. Voir source | 42402238 | 10.1016/j.compbiomed.2026.111839 | Computers in biology and medicine |
Sources officielles
liens de rechercheDernière mise à jour des données : 2026-10-19
Ces sources sont proposées pour vérification. Les informations de la fiche doivent être confirmées dans les registres officiels ou les publications originales.